That's a fair question, LR. Lemoncat would probably say that it was Polymedix that made this ph2b spend, and not him. That's fair too. So, the bigger question is why ipix keeps doing tiny trials. That's on him, the bigger question. Also, the question is why this platform can't be sold asap if it has the cure for covid, UC, UP and OM and absssi. drugs always being bought, why hasn't brilacidin. it doesn't need a ph3 to sell it. drugs are bought all the time for BILLIONS BEFORE EVEN STARTING PHASE 1. Holy cow. get it done now. Enough small ball and a cpa pretending to play ceo land. time to sell and play with material objects and go on exotic vacations.
Market Data 
Markets 
